Investors purchased shares of Zimmer Biomet Holdings Inc. (NYSE:ZBH) on weakness during trading on Wednesday. $133.88 million flowed into the stock on the tick-up and $80.68 million flowed out of the stock on the tick-down, for a money net flow of $53.20 million into the stock. Of all equities tracked, Zimmer Biomet Holdings had the 5th highest net in-flow for the day. Zimmer Biomet Holdings traded down ($4.17) for the day and closed at $128.92

A number of brokerages have recently issued reports on ZBH. Jefferies Group reissued a “buy” rating and issued a $150.00 target price on shares of Zimmer Biomet Holdings in a research report on Monday. JMP Securities boosted their target price on shares of Zimmer Biomet Holdings from $131.00 to $145.00 and gave the company a “market outperform” rating in a research report on Friday, July 29th. JPMorgan Chase & Co. boosted their target price on shares of Zimmer Biomet Holdings from $134.00 to $148.00 and gave the company an “overweight” rating in a research report on Friday, July 29th. BMO Capital Markets reissued a “buy” rating and issued a $146.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday, July 29th. Finally, Needham & Company LLC boosted their price target on Zimmer Biomet Holdings from $143.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, July 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and twenty have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $130.45.

The stock has a 50-day moving average price of $124.79 and a 200-day moving average price of $112.67. The firm has a market cap of $25.71 billion and a PE ratio of 117.74.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Thursday, July 28th. The company reported $2.02 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.05. The business earned $1.93 billion during the quarter, compared to analysts’ expectations of $1.90 billion. The business’s revenue was up 65.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.58 EPS. On average, equities analysts anticipate that Zimmer Biomet Holdings Inc. will post $7.97 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, July 29th. Shareholders of record on Friday, June 24th were issued a $0.24 dividend. The ex-dividend date was Wednesday, June 22nd. This represents a $0.96 annualized dividend and a dividend yield of 0.74%.

In other Zimmer Biomet Holdings news, CAO Tony W. Collins sold 3,611 shares of the firm’s stock in a transaction dated Tuesday, June 14th. The stock was sold at an average price of $116.43, for a total value of $420,428.73. Following the sale, the chief accounting officer now owns 3,245 shares of the company’s stock, valued at approximately $377,815.35. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Stuart G. Kleopfer sold 11,000 shares of the firm’s stock in a transaction dated Thursday, June 9th. The shares were sold at an average price of $119.45, for a total value of $1,313,950.00. Following the completion of the sale, the insider now directly owns 7,609 shares in the company, valued at approximately $908,895.05. The disclosure for this sale can be found here.

Several hedge funds have added to or reduced their stakes in ZBH. Employees Retirement System of Texas acquired a new stake in Zimmer Biomet Holdings during the fourth quarter valued at $1,026,000. Liberty Mutual Group Asset Management Inc. purchased a new position in shares of Zimmer Biomet Holdings during the fourth quarter worth $1,029,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new position in shares of Zimmer Biomet Holdings during the fourth quarter worth $1,147,000. Advisors Asset Management Inc. purchased a new position in shares of Zimmer Biomet Holdings during the fourth quarter worth $1,234,000. Finally, Andra AP fonden purchased a new position in shares of Zimmer Biomet Holdings during the fourth quarter worth $1,600,000.

Zimmer Biomet Holdings, Inc, formerly Zimmer Holdings, Inc, is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.